Discontinuation of Fumaric Acid Esters is Affected by Depressive Symptomatology: A Retrospective Analysis
Fumaric acid esters (FAEs) remain a widespread therapy option for moderate-to-severe psoriasis. However, drug survival of FAEs is limited by adverse events (AEs) or inadequate treatment response. Depressive disturbances are highly prevalent in psoriasis patients and are hypothesized to be associated...
Main Authors: | Frederik Krefting, Stefanie Hölsken, Manfred Schedlowski, Wiebke Sondermann |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Journals Sweden
2024-03-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: | https://medicaljournalssweden.se/actadv/article/view/12326 |
Similar Items
-
A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis
by: Michelle Allan, et al.
Published: (2019-12-01) -
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
by: Stephanie Kourakis, et al.
Published: (2020-10-01) -
Long-term use of fumaric acid esters for the treatment of psoriasis in daily practice
by: Christian Termeer, et al.
Published: (2021-08-01) -
The Antineoplastic Effect of Dimethyl Fumarate on Virus-Negative Merkel Cell Carcinoma Cell Lines: Preliminary Results
by: Thilo Gambichler, et al.
Published: (2023-01-01) -
New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
by: Paolinelli Matteo, et al.
Published: (2022-12-01)